Direct compression of nicotinic acid-containing formulations is constrained by the crystalline habit, low bulk density, and high elastic recovery of pyridine-3-carboxylic acid when blended with microcrystalline cellulose, lactose monohydrate, or dicalcium phosphate carriers at rotary press speeds above 60,000 tablets/h. Moisture-redefined granulation operates between dry blending and conventional wet granulation by introducing 1.0% to 4.0% w/w of purified water or an aqueous binder solution into a pre-blended matrix, followed by wet massing under controlled shear until a measurable torque increase occurs, and subsequent drying to a target loss-on-drying of 0.5% to 2.0%. The substitution of nicotinic acid into direct compression formulations therefore requires re-engineering the moisture addition sequence because the carboxylic acid functionality can form hydrates, acid-base adducts, and low-temperature eutectics with water-soluble carriers. Process validation batches for such systems rely on USP <616> for bulk and tapped density, USP <786> for particle size distribution by analytical sieving, USP <905> for content uniformity, USP <711> for dissolution, USP <1216> for friability, and USP <1217> for tablet breaking force. In-process sampling requirements under FDA 21 CFR 211.110(a) demand that granule moisture, particle size, and blend potency be monitored after the drying step and before compression. Published data for nicotinic acid-specific moisture-redefined granulation is limited, but the general process window can be derived from low-dose acidic active pharmaceutical ingredients with similar aqueous solubility, crystal surface energy, and compactibility limitations. The moisture-redefined granulation step must simultaneously improve weight uniformity in the die and preserve the disintegration and dissolution performance of the direct compression system, which places stricter limits on water distribution than are required for conventional high-shear wet granulation of neutral or weakly basic drug substances.
Moisture redistribution within a direct compression granule containing nicotinic acid, microcrystalline cellulose, and partially pregelatinized starch is governed by the water activity gradient between the spray droplet, the hydrophilic carrier, and the crystalline drug surface. The moisture-redefined granulation endpoint is not a wet mass in the conventional sense; rather, the water acts as a transient plasticizer that lowers the glass transition temperature of amorphous regions in microcrystalline cellulose and starch. If the water activity exceeds 0.45, hygroscopic carriers can retain surface moisture after drying, causing picking and sticking during compression at dwell times below 10 ms. Conversely, water activity below 0.25 fails to form granule nuclei of sufficient strength, yielding friable agglomerates that segregate during transfer to the press hopper. Dynamic vapor sorption data at 25 °C for microcrystalline cellulose indicate a moisture uptake of approximately 5% to 8% w/w between 40% and 70% relative humidity; therefore, the post-drying specification for loss-on-drying must be tightened to 0.8% to 1.2% when the ambient relative humidity during compression exceeds 50%. The crystalline domains of nicotinic acid remain largely unaffected by moist massing, but surface dissolution of fine drug particles creates amorphous or hydrated zones that recrystallize during drying, increasing the friability of the dried granules. For this reason, the granulation fluid should be added in a split-spray sequence rather than a single bolus to limit localized oversaturation and the formation of large, hard agglomerates with high residual moisture. Sieve analysis according to USP <786> should be performed after drying and before the addition of the extra-granular disintegrant; the target granule fraction between 125 µm and 850 µm should represent at least 60% of the total mass to maintain die fill uniformity. During equipment scale-up, the water distribution pattern in a 300 L high-shear granulator with a bottom-drive impeller may require an increase in the spray nozzle atomization air pressure to 2.0 to 3.0 bar, because the larger bed volume extends the droplet penetration path and increases the probability that water will preferentially wet the microcrystalline cellulose fines rather than the nicotinic acid crystals. The resulting granule size distribution must be evaluated with a rotary sieve shaker, and the mass fraction below 75 µm should be kept below 20% to avoid punch sticking and excessive dust generation during compression.
In formulations where nicotinic acid constitutes more than 40% w/w of the final granule mass, the high brittle-fracture tendency of the drug substance competes with the plastic deformation of microcrystalline cellulose and the rapid disintegration of the granule matrix. The granulation process must be controlled not by granulation time alone but by a combination of impeller torque, product temperature, and mass-level water addition. In a high-shear mixer with a chopper speed of 1,500 to 3,000 rpm and an impeller tip speed of 2.0 to 6.0 m/s, the wet mass torque curve typically rises from a dry-mix baseline of 10 to 20 N·m to an endpoint range of 35 to 55 N·m for a 600 L bowl, depending on the binder type and the surface moisture of the drug substance. The addition of water at 1.5% to 2.5% w/w above the dry-mix mass is often sufficient to generate granule nuclei, but nicotinic acid-rich blends may require the aqueous binder to contain povidone K30 at a concentration of 2.0% to 5.0% w/w, producing a solution viscosity of 5.5 to 8.5 mPa·s at 25 °C. The pKa of the carboxylic acid group allows salt formation with basic excipients; consequently, the binder pH should be kept between 5.0 and 6.5 to reduce drug-excipient ionization and subsequent dissolution changes. When the nicotinic acid content exceeds 40% w/w, the dried granules exhibit higher elastic recovery during tableting because the drug crystals do not deform plastically and may fracture at punch pressures above 150 MPa, increasing the risk of capping at tablet thicknesses below 3.0 mm. A compaction force-displacement profile measured on an instrumented single-punch press should be evaluated according to USP <1217>; the plastic work fraction of the blend should remain above 0.35 of the total work of compaction to maintain tensile strength without excessive brittle drug fracture. If the plastic work fraction falls below 0.25, the formulation requires a pre-granulation wetting step with a lower-viscosity binder or substitution of a portion of the extra-granular microcrystalline cellulose with a spray-dried lactose carrier to improve compactibility. The granule strength must also be correlated with the disintegration time of the compressed tablet; over-wetting during moisture-redefined granulation can create a dense peripheral shell that delays water penetration and slows the release of nicotinic acid below the compendial acceptance threshold.
Process controls for moisture-redefined granulation of nicotinic acid direct compression blends in high-shear mixers are tightly coupled to the hydraulic spray delivery system, the impeller speed, and the in-process moisture analyzer. The spray nozzle should be positioned to deliver the aqueous binder at a mass flow rate of 0.4 to 1.2 kg/min per 100 kg of dry powder in a 600 L bowl, with atomization air pressure maintained between 1.5 and 3.5 bar. The impeller speed should be increased from the dry blending setting of 70 to 90 rpm to a wet massing setting of 110 to 140 rpm only after the first water addition, because premature high shear can increase the temperature above 28 °C and accelerate water migration out of the granule pores. The chopper is typically operated for 30 to 60 s after each water addition to disperse oversized nuclei; the final wet massing time should not exceed 180 s to avoid over-granulation that closes the granule surface porosity and prolongs drying. The endpoint loss-on-drying measured by an infrared moisture balance at 105 °C should be 0.8% to 1.5% w/w after fluid-bed drying at inlet air temperature 50 to 65 °C, with product temperature not exceeding 42 °C to avoid melting of any amorphous binder phase or dehydration of dicalcium phosphate dihydrate. Drying below 1.0% residual moisture can be counterproductive because the granule surface loses the small plasticizing water layer that enhances particle rearrangement during compression; drying above 2.0% residual moisture increases the risk of picking and sticking on the tablet press. The granulated material should be passed through a 1.0 mm conical mill equipped with a round-hole screen at 600 to 1,000 rpm to normalize granule size without destroying the moisture-redefined agglomerates. A systematic comparison of representative process control limits is provided in the following table.
| Parameter | ≤10% w/w nicotinic acid | 10–40% w/w nicotinic acid | Above 40% w/w nicotinic acid |
|---|---|---|---|
| Granulation fluid water content, % w/w of dry blend | 1.0–2.0 | 1.5–3.0 | 2.0–4.0 |
| Impeller tip speed, m/s | 2.0–4.0 | 3.0–5.0 | 4.0–6.0 |
| Final loss-on-drying, % w/w | 0.5–1.2 | 0.8–1.5 | 1.0–2.0 |
| Target granule fraction 125–850 µm, % | ≥65 | ≥60 | ≥55 |
| Extra-granular microcrystalline cellulose, % w/w final blend | 10–20 | 15–25 | 20–30 |
Substitution of a portion of the microcrystalline cellulose carrier with dicalcium phosphate dihydrate in a nicotinic acid direct compression formulation alters the moisture-redefined granulation mechanism because dicalcium phosphate dihydrate is non-hygroscopic, brittle, and thermally labile with respect to lattice water release above 40 to 50 °C under prolonged drying. The granule strength derived from moisture-redefined granulation depends on the formation of solid bridges after water evaporation from soluble binder and partially dissolved carrier surfaces; dicalcium phosphate dihydrate contributes little to this bridge-forming network at moisture levels below 2.0% w/w and may instead act as a hard, non-deformable diluent that reduces the plastic work fraction of the tablet formulation. When dicalcium phosphate dihydrate substitutes for 25% to 50% of the microcrystalline cellulose in a formulation containing 20% nicotinic acid, the impeller torque endpoint must be raised because the dry blend has a higher bulk density and a lower compressibility, requiring additional binder wetting to reach an acceptable granule size. However, the drying step must then be shortened or the inlet air temperature lowered to avoid dehydration of the dihydrate, which can cause weight loss and friability drift. Loss-on-drying values alone are insufficient to distinguish residual surface moisture from dicalcium phosphate dihydrate lattice water; therefore, a thermogravimetric method with a heating rate of 10 °C/min from 30 °C to 200 °C is necessary to quantify free water and bound water separately. The presence of free carboxylic acid groups on nicotinic acid may accelerate the dehydration of dicalcium phosphate dihydrate at acidic micro-pH environments, particularly when the granulation fluid has a pH below 4.0; published data for this specific drug-dihydrate configuration is limited, but the known acid-catalyzed dehydration of calcium hydrogen phosphate dihydrate supports strict control of contact time and drying temperature. The compression step should be re-validated when dicalcium phosphate dihydrate substitution exceeds 30% because the ejection force at a tablet press speed of 40,000 tablets/h can increase due to the brittle fragmentation of dicalcium phosphate dihydrate particles and the reduced lubricant surface coverage of the granule mass. Tablet surfaces should be inspected for lamination after compression because the interface between the hard dihydrate particles and the plastically deformable microcrystalline cellulose domains can act as a crack initiation site under high compression pressure.
Residual moisture after moisture-redefined granulation influences both the dissolution kinetics and the physical stability of nicotinic acid direct compression tablets. The dissolution testing per USP <711> with apparatus 2 at 50 rpm in 900 mL of 0.1 N hydrochloric acid is the standard release condition for immediate-release niacin tablets, although published data for this specific configuration is limited. The moisture-redefined granules should be blended with extra-granular disintegrant such as crospovidone at 2.0% to 5.0% w/w and lubricant such as sodium stearyl fumarate at 0.5% to 1.5% w/w; magnesium stearate should be limited to below 1.0% w/w because the hydrophobic film can interact with the acidic drug surface and slow dissolution. Tablets compressed to a hardness of 60 to 120 N according to USP <1217> and a friability below 0.8% according to USP <1216> should be assessed for content uniformity according to USP <905> with an acceptance value of not more than 15. The following compliance matrix summarizes the test designations and the corresponding release or in-process limits.
| Test designation | Measurement | Release or in-process limit |
|---|---|---|
| USP <616> | Bulk and tapped density | Carr index ≤ 25, Hausner ratio ≤ 1.35 |
| USP <786> | Granule particle size distribution | 125–850 µm fraction ≥ 60% w/w |
| USP <1216> | Tablet friability | ≤ 0.8% weight loss after 100 drops |
| USP <1217> | Tablet breaking force | 60–120 N for 10.3 mm round tooling |
| USP <711> | Dissolution | Q ≥ 75% at 45 min in 0.1 N HCl |
| USP <905> | Content uniformity | Acceptance value ≤ 15 |
Compression of moisture-redefined nicotinic acid granules must be limited to a compression room relative humidity below 60%; if ambient relative humidity exceeds 60%, pre-drying of extra-granular disintegrant and lubricant blending is required to avoid moisture uptake that can cause punch adhesion and weight variability. The direct compression blend should not be stored for more than 72 h before compression because residual moisture gradients can promote drug migration and content uniformity drift. The combination with amine-functionalized excipients such as amino methacrylate copolymer or strongly basic disintegrants should be avoided unless compatibility testing demonstrates no dissolution shift; the carboxylic acid group of nicotinic acid can form salts or adducts that change the effective drug solubility and release rate. Tablet hardness should be maintained at 60 to 120 N, friability below 0.8% per USP <1216>, and ejection forces below 1,500 N to protect the press tooling and maintain dwell time stability. For high-shear granulation batches where the moisture addition exceeds 3.0% w/w, the granulation bowl discharge port should be monitored for wet residue accumulation, and the drying bowl should be loaded in a manner that avoids particle segregation due to differences in bulk density between the nicotinic acid-rich granules and the fines fraction.